BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1088 related articles for article (PubMed ID: 18985950)

  • 1. Medicare program: Medicare Advantage and Prescription Drug Benefit programs: final marketing provisions. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2008 Sep; 73(182):54207-23. PubMed ID: 18985950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicare Program; revisions to the Medicare Advantage and Prescription Drug Benefit programs. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2008 Sep; 73(182):54225-54. PubMed ID: 18985953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicare program; Medicare prescription drug benefit. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicare program; Medicare Advantage and prescription drug benefit programs: negotiated pricing and remaining revisions. Final rule with comment period.
    Fed Regist; 2009 Jan; 74(7):1493-549. PubMed ID: 19143114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicare program; establishment of the Medicare advantage program. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4587-741. PubMed ID: 15678604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicare program; revisions to the Medicare Advantage and prescription drug benefit programs: clarification of compensation plans. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2008 Nov; 73(221):67406-14. PubMed ID: 19137670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicare program; changes to the Medicare Advantage and the Medicare prescription drug benefit programs for contract year 2013 and other changes. Final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2012 Apr; 77(71):22072-175. PubMed ID: 22606715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicare program; Medicare Advantage and prescription drug benefit programs. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2011 Sep; 76(170):54600-35. PubMed ID: 21894660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicare program: Medicare Advantage and prescription drug programs MIPPA drug formulary & protected classes policies. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2009 Jan; 74(11):2881-8. PubMed ID: 19385109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicare and state health care programs; fraud and abuse: OIG civil money penalties under the Medicare prescription drug discount card program. Interim final rule with comment period.
    Office of Inspector General (OIG), HHS
    Fed Regist; 2004 May; 69(97):28842-6. PubMed ID: 15151115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicare program; Medicare prescription drug discount card; revision of marketing rules for endorsed drug card sponsors. Final rule.
    Centers for Medicare & Medicaid Services, HHS
    Fed Regist; 2005 Sep; 70(169):52019-23. PubMed ID: 16138430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicare Part D: successes and continuing challenges. Impact of Medicare Part D on Massachusetts health programs and beneficiaries.
    Thomas CP; Sussman J; ;
    Issue Brief (Mass Health Policy Forum); 2007 May; (32):1-32. PubMed ID: 17546802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
    Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
    Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicare program; Medicare prescription drug benefit; interpretation. Final rule; interpretation.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Mar; 70(53):13397-400. PubMed ID: 15786588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicare program; medical loss ratio requirements for the Medicare Advantage and the Medicare Prescription Drug Benefit Programs.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2013 May; 78(100):31283-313. PubMed ID: 23705177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicare and state health care programs; fraud and abuse: OIG civil money penalties under the Medicare prescription drug discount card program. Final rule.
    Office of Inspector General (OIG), HHS
    Fed Regist; 2004 Dec; 69(239):74451-3. PubMed ID: 15597491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicare program; changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs for contract year 2012 and other changes. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2011 Apr; 76(73):21431-577. PubMed ID: 21513175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicaid program; prescription drugs. Final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2007 Jul; 72(136):39141-245. PubMed ID: 17674494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing prescription drug plans. New choices made available by Medicare Part D deserve serious study.
    AVMA Group Health & Life Insurance Trust
    J Am Vet Med Assoc; 2005 Dec; 227(12):1884-5. PubMed ID: 16382541
    [No Abstract]   [Full Text] [Related]  

  • 20. Medicare program; policy and technical changes to the Medicare Advantage and the Medicare prescription drug benefit programs. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2010 Apr; 75(72):19677-826. PubMed ID: 20422785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.